IceCure Medical Ltd (ICCM) Tops Q2 EPS by 18c

IceCure Medical Ltd (NASDAQ: ICCM) reported Q2 EPS of $0.12, $0.18 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $1.25 million versus the consensus estimate of $900.5 thousand.

For earnings history and earnings-related data on IceCure Medical Ltd (ICCM) click here.

You May Also Be Interested In

• BofA lists top 5 themes driving next $1tn in incremental semi sales
• Safe Pro wins $1.3M U.S. Army subcontract for AI landmine detection
• IceCure cites journal article on cryoablation vs. RFA for breast cancer